Tracking new kidney anemia drug in real patients
NCT ID NCT07346547
Summary
This study creates a registry to observe how patients with anemia from chronic kidney disease respond to the oral medication daprodustat in real-world settings. Researchers will track 384 adult patients who are already taking or starting this medication to understand treatment patterns, effectiveness, and safety outcomes. The goal is to gather practical information to help improve care guidelines for this condition.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CKD ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.